Capricor Therapeutics | CAPR - Current Liabilities


Capricor Therapeutics reported $32.96M in Current Liabilities for its fiscal quarter ending in June of 2026.





Current Liabilities Change Date
Alterity Therapeutics Limited AUD 1.73M 2.77M Dec/2025
Bioline Rx USD 13.62M 1.5M Mar/2026
Capricor Therapeutics USD 32.96M 676K Jun/2026
Cipla INR 70.14B 7.16B Mar/2026
Cytokinetics USD 181.43M 17.76M Jun/2026
Geron USD 70.33M 3.24M Jun/2026
Grifols EUR 2.37B 156.97M Dec/2025
Immunic USD 38.36M 7.74M Mar/2026
J&J USD 54.9B 2.82B Jun/2026
Plus Therapeutics USD 8.57M 612K Jun/2026
Prothena USD 11.66M 20.86M Jun/2026
PTC Therapeutics USD 771.07M 152.54M Jun/2026
Sarepta Therapeutics USD 502.91M 3.74M Jun/2026